Immunization of HLA-A1 and/or HLA-A2 positive patients
HLA-A1 and/or HLA-A2 positive patients are immunized with autologous DC loaded with KLH, as immunological tracer, and an allogeneic peptidome (i.e. natural tumour peptides, NTPs), obtained from melanoma cell line SK-Mel24.
protocol
Clinical protocol
Clinical trials of active vaccination in metastatic melanoma patients
Maria Pia Protti
Autologous DC loaded with KLH and an allogeneic peptidome
HLA-A1 positive patients
HLA-A2 positive patients